Internal Medicine, Pulmonary Disease · Ypsilanti, MI
NPI
1093835373
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
5333 McAuley Dr, Suite 3111
Ypsilanti, MI, 48197
Phone (734) 712-7688
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
1,718 services
Medicare patients, 2024
717
Average age 73
Drug cost, 2024
$1.8M
3,791 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Urvashi Bhan was code 99214 (office e&m - established), 374 times for 294 patients. In total Urvashi Bhan billed 1,718 services in 33 codes, and Medicare paid $142K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 374 | 294 | $95.05 | $36K |
| 99291 Critical Care E&M | Facility | 176 | 90 | $165.02 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 171 | 151 | $13.00 | $2,224 |
| 99215 Office E&M - Established | Office | 143 | 106 | $134.12 | $19K |
| 99205 Office E&M - New | Office | 133 | 133 | $159.79 | $21K |
| 94010 Pulmonary Function Testing | Office | 116 | 105 | $19.53 | $2,265 |
| 94729 Pulmonary Function Testing | Office | 112 | 108 | $40.61 | $4,548 |
| 99213 Office E&M - Established | Office | 65 | 63 | $60.44 | $3,928 |
| 99223 Hospital E&M - Initial | Facility | 59 | 55 | $138.07 | $8,146 |
| 94729 Pulmonary Function Testing | Facility | 56 | 56 | $5.86 | $328 |
| 94726 Pulmonary Function Testing | Facility | 49 | 49 | $7.74 | $379 |
| 94726 Pulmonary Function Testing | Office | 48 | 48 | $40.19 | $1,929 |
| 99233 Hospital E&M - Subsequent | Facility | 46 | 34 | $94.81 | $4,361 |
| 99204 Office E&M - New | Office | 32 | 32 | $127.57 | $4,082 |
| 94010 Pulmonary Function Testing | Facility | 29 | 29 | $5.29 | $153 |
By year: 2022 $157K for 1,544 services; 2023 $151K for 1,625 services; 2024 $142K for 1,718 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87635 COVID Specific | 21 | 21 | $50.28 | $1,056 |
Medicare prescription drug claims, 2024
In 2024, the drug Urvashi Bhan prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 610 prescriptions and refills. In total Urvashi Bhan wrote 3,791 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 610 | 1,143 | 174 | $701K |
| Prednisone Generic | 377 | 494 | 213 | $1,370 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 368 | 813 | 168 | $117K |
| Azithromycin Generic | 291 | 604 | 146 | $3,749 |
| Breo Ellipta Fluticasone/Vilanterol | 257 | 414 | 67 | $158K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 188 | 293 | 89 | $9,643 |
| Ipratropium Bromide Generic | 182 | 318 | 85 | $5,547 |
| Spiriva Respimat Tiotropium Bromide | 179 | 273 | 53 | $136K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 174 | 214 | 42 | $97K |
| Tiotropium Bromide Generic | 152 | 342 | 59 | $122K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 114 | 232 | 57 | $35K |
| Symbicort Budesonide/Formoterol Fumarate | 101 | 155 | 31 | $34K |
| Incruse Ellipta Umeclidinium Bromide | 95 | 136 | 32 | $46K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 95 | 153 | 34 | $32K |
| Spiriva Handihaler Tiotropium Bromide | 80 | 146 | 20 | $71K |
Brand drugs: 2,150 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Urvashi Bhan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.